Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-017350-13Phase 4Completed
Phase 4, open-label, single-arm trial of oseltamivir in Influenza A infection, sponsored by Erasmus Hospital. Primary endpoint: Pharmacokinetic parameters of oseltamivir and its active metabolite. Started Nov 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-017350-13.